DDReg is thrilled to announce that it has made it as a finalist for the CPHI Pharma Awards 2023. With 12 categories and 180 submissions, DDReg was shortlisted under the ‘Regulatory’ category for its entry on Technology-Enabled Regulatory Services through Vitalic®.
Indeed, this is a testament to DDReg’s commitment towards regulatory excellence and innovation. Read about the nomination in this month’s BioPharma Dive press release in which DDReg has featured for its entry: DDReg Shortlisted for CPHI Pharma Awards 2023 | BioPharma Dive
The Business Development team looks forward to being present at this prestigious events. Reach out to the team at bd@ddregpharma.com to schedule a meeting.
Good luck to all other finalists!